Advertisement

Pharmacy

Pfizer received FDA approval May 6 for Vyndaqel, which treats a rare and fatal heart disease. The drug will launch with a list price of $225,000 per year in the U.S., according to Reuters.

A federal judge has denied Aetna's bid to derail a whistleblower suit against CVS Caremark that alleges the pharmacy benefit manager overbilled Medicare by more than $1 billion for prescription drugs, according to The Columbus Dispatch.

Relative to nationwide averages for the cost of the 500 most commonly prescribed medications, Atlanta is the least expensive city to purchase those drugs, according  according to GoodRx's inaugural quarterly report, an in-depth analysis of drug prices and fill rates…

Advertisement

Insys Therapeutics founder John Kapoor and four other executives were convicted May 2 of a racketeering conspiracy that boosted sales of a highly addictive opioid, helping drive the opioid crisis in the U.S., according to Reuters.

Gilead Sciences will lose its longtime CFO Robin Washington in March 2020, according to Endpoints News.

Advertisement